Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression.

Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression.

BACKGROUND: Substantial residual cardiovascular risk remains after optimal LDL lowering in patients of established coronary artery disease. A number of therapeutic agents that raise HDL-C have been tested in clinical trials to cover this risk. However, the results of clinical trials are conflicting....

Full description

Bibliographic Details
Main Authors: Navjot Kaur, Avaneesh Pandey, Harish Negi, Nusrat Shafiq, Srinivas Reddy, Harpreet Kaur, Neelima Chadha, Samir Malhotra
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3984171?pdf=render

Similar Items

Similar Items